Sarah Deleu
- Hematology top 10%
- Multiple Myeloma Research and Treatments 6
-
- Peptidase Inhibition and Analysis 4
-
- Protein Degradation and Inhibitors 7
- Histone Deacetylase Inhibitors Research 7
- Ubiquitin and proteasome pathways 1
- Phytochemical compounds biological activities 1
- Epigenetics and DNA Methylation 1
- Co-authors
- Karin VanderkerkenMiguel LemaireEline MenuEls Van ValckenborghIsabelle Vande BroekElke De BruyneHendrik De RaeveJanine Arts
- Cited by
- HematologyOncologyMolecular Biology
- Partner nations
- BelgiumUnited StatesUnited Kingdom
In The Last Decade
Sarah Deleu
8 papers receiving 262 citations
Peers
Comparison fields: 5 of 35
- Hematology 150
- Oncology 95
- Molecular Biology 208
- Cancer Research 22
- Immunology 21
Countries citing papers authored by Sarah Deleu
This map shows the geographic impact of Sarah Deleu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Deleu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Deleu more than expected).
Fields of papers citing papers by Sarah Deleu
This network shows the impact of papers produced by Sarah Deleu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Deleu. The network helps show where Sarah Deleu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarah Deleu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 60 | |
| 2 | 2010 | 76 | |
| 3 | 2009 | 47 | |
| 4 | 2009 | 57 | |
| 5 | 2009 | 8 | |
| 6 | 2009 | 0 | |
| 7 | 2008 | 10 | |
| 8 | Screening of Trichostatin Analogues Based on Cellular Potency in the Murine Multiple Myeloma 5T33MM Model | 2008 | 2 |
| 9 | 2007 | 2 |
About Sarah Deleu
Sarah Deleu is a scholar working on Hematology, Oncology and Molecular Biology, having authored 9 papers that have together received 262 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (7 papers), Histone Deacetylase Inhibitors Research (7 papers), Multiple Myeloma Research and Treatments (6 papers), Peptidase Inhibition and Analysis (4 papers), Ubiquitin and proteasome pathways (1 paper), Phytochemical compounds biological activities (1 paper) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Hematology (150 citations), Oncology (95 citations) and Molecular Biology (208 citations). Sarah Deleu has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Karin Vanderkerken, Miguel Lemaire, Eline Menu, Els Van Valckenborgh, Isabelle Vande Broek, Elke De Bruyne, Hendrik De Raeve, Janine Arts, Peter I. Croucher and Mårten Fryknäs. Their work appears in journals such as Blood, Investigational New Drugs, Leukemia, Advances in cancer research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.